Pharmacy to Dose: The Critical Care Podcast
Trial of the Week: Levetiracetam Rapid IV Push
Mar 1, 2024
Pharmacist Olivia Morgan discusses the safety and tolerability of rapidly administering undiluted levetiracetam, highlighting findings from a neurocritical care study. The podcast covers changes in administration techniques, protocol updates, administering other anti-seizure medications via rapid IV push, and exploring potential higher doses of levetiracetam.
28:03
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The study focused on the safety and tolerability of rapid undiluted administration of levetiracetam, highlighting the shift towards a more efficient medication delivery process.
- The episode discussed the potential expansion of rapid administration protocols to other anti-seizure drugs, emphasizing the need for continuous improvement in medication administration practices.
Deep dives
Research Trial on Rapid Administration of Undiluted Levetiracetam
The episode discusses a research trial focusing on changing the administration of the anti-seizure medication levetiracetam. The study explored the safety and tolerability of rapid undiluted administration of levetiracetam, which aimed to streamline the medication administration process. It highlighted the shift from prior methods of compounding the drug to using undiluted vials, emphasizing the importance of practical and efficient care delivery. The trial's findings, implications, and expansion of this new protocol within and outside the institution were discussed, along with the potential for similar approaches with other anti-seizure medications.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
